Cargando…
Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements
Colorectal cancer results in the deaths of hundreds of thousands of patients worldwide each year, with incidence expected to rise over the next two decades. In the metastatic setting, cytotoxic therapy options remain limited, which is reflected in the meager improvement of patient survival rates. Th...
Autores principales: | Cann, Christopher G., LaPelusa, Michael B., Cimino, Sarah K., Eng, Cathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319053/ https://www.ncbi.nlm.nih.gov/pubmed/37409250 http://dx.doi.org/10.3389/fonc.2023.1176950 |
Ejemplares similares
-
Targeted therapies in advanced biliary tract cancers—a narrative review
por: LaPelusa, Michael, et al.
Publicado: (2023) -
Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer
por: LaPelusa, Michael, et al.
Publicado: (2022) -
Up-and-Coming Experimental Drug Options for Metastatic Colorectal Cancer
por: Cimino, Sarah K, et al.
Publicado: (2020) -
Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma—A Narrative Review
por: Chamseddine, Shadi, et al.
Publicado: (2023) -
Trends in the Incidence and Treatment of Early-Onset Pancreatic Cancer
por: LaPelusa, Michael, et al.
Publicado: (2022)